Adaptimmune Therapeutics Plc Free Cash Flow Generation Index
Adaptimmune Therapeutics Plc free cash flow generation index. Adaptimmune Therapeutics Plc (ADAP) has a Free Cash Flow Generation Index of 0.98x as of June 2024. Free cash flow of $46.63 Million represents 1% of operating cash flow ($47.39 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Adaptimmune Therapeutics Plc (2013–2021)
Free cash flow generation index of Adaptimmune Therapeutics Plc from 2013 to 2021. Historical FCF Generation Index trend for Adaptimmune Therapeutics Plc across 2 annual periods. See how financially flexible is Adaptimmune Therapeutics Plc to measure the company's free cash flow as a share of total liabilities.
Adaptimmune Therapeutics Plc Free Cash Flow Generation Index by Year (2013–2021)
Adaptimmune Therapeutics Plc free cash flow generation index by year from 2013 to 2021. Year-by-year Free Cash Flow Generation Index for Adaptimmune Therapeutics Plc. For the full cash flow conversion analysis, see Adaptimmune Therapeutics Plc (ADAP) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.18x | $1.95 Million | $10.73 Million | $8.78 Million | ▼ -81.1% |
| 2013 | 0.96x | $35.78 Million | $37.23 Million | $1.45 Million | — |